Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide , a dual GIP/GLP-1 receptor agonist, has been approved in the UK for type 2 diabetes (as Mounjaro) but at the time of writing is not licensed by the MHRA specifically for weight management
Increased GH and IGF-1 Levels: Mod GRF 1-29 transiently stimulates growth hormone production by targeting the pituitary gland, leading to pulsatile increases in GH levels and secondary rises in IGF-1 (1)
This led to investigations into broader health benefits, including potential anti-inflammatory effects
IGF-DES and Cardiovascular Biology Research IGF-1 signalling mediated by the same IGF-1R that IGF-DES engages regulates cell division, proliferation, and survival, with ERK/MAPK and PI3K/Akt representing the main pathways involved in IGF-1 signal transduction
US$ 27.18
US$ 28.82
US$ 21.41
US$ 27.70
